UTMB develops a universal vaccine platform that’s cheaper and shelf stable
Researchers at The University of Texas Medical Branch at Galveston have developed a less expensive way to produce vaccines that cuts the cost of vaccine production and storage by 80 percent without decreasing safety or effectiveness. The findings are currently available in EBioMedicine.
Vaccines are the most effective way to prevent and eradicate infectious diseases. Currently, many vaccines have to be manufactured in cell culture or eggs, which is expensive and carries the risk of contaminations. In addition, most vaccines must be kept refrigerated during the transportation from manufacturers to health care clinics. In tropical and subtropical regions, such cold storage requirements could contribute to more than 80 percent of the vaccine cost.
“The ability to eliminate cell culture or eggs and cold storage will change the process of vaccine development,” said UTMB’s Pei-Yong Shi, professor in the department of biochemistry and molecular biology. “Importantly, this vaccine technology could potentially serve as a universal platform for development of live-attenuated vaccines for many viral pathogens.”
To achieve these goals, the UTMB team engineered a live-attenuated Zika vaccine in the DNA form. Once the DNA is delivered into our body, it launches the vaccine in our cells, leading to antibody production and other protective immunity. With this production method, there is no need to manufacture the vaccine in cell culture or eggs at factories. Because DNA molecules are shelf stable, the vaccine will not expire at warm temperatures and could be stockpiled at room temperature for years.
Using UTMB’s Zika vaccine as a model, the research group showed that the DNA platform worked very efficiently in mice. After a single low dose, the DNA vaccine protected mice from Zika virus infection, mother-to-fetus transmission during pregnancy and male reproductive tract infection and damage.
“This is the first study to demonstrate that, after a single low dose, a DNA vaccine could induce saturated protective immunity,” Shi said. “We will continue testing this promising Zika vaccine platform and then apply the platform to other viruses.”
Receive an email update when we add a new VACCINES article.
The Latest on: Vaccine production
via Google News
The Latest on: Vaccine production
- Innovation in Vaccine Production Technology Could Make the Vaccines Cheaper on October 6, 2018 at 8:00 am
To bring down the production and storage cost of Vaccines, the Researchers at The University of Texas have developed a way to deliver vaccines right into the cells as DNA. Once the DNA is delivered in... […]
- S. Korea Unlikely to Attain Its Vaccine Self-Sufficiency Goal by 2020 on October 3, 2018 at 7:01 pm
Korea's vaccine self-sufficiency rate increased to 53.5% this year, setting a new record. The South Korean government is unlikely to attain its goal of boosting the nation's vaccine self-sufficiency r... […]
- Vietnam ready for production of two influenza vaccines on September 24, 2018 at 9:44 pm
The Institute of Vaccines and Medical Biologicals (IVAC) has completed the clinical trials of two types of seasonal influenza vaccine, which are expected to receive approval for commercial use in ... […]
- China to improve financial supervision, reform vaccine production on September 20, 2018 at 8:29 am
BEIJING (Reuters) - China will strengthen the coordination of supervision over “systematically important” financial institutions, state television said on Thursday, citing a central government meeting ... […]
- Medicago begins construction of vaccine production plant in Quebec City on September 20, 2018 at 3:58 am
Medicago, a Canadian biotech company and global leader in the development and production of plant-based vaccines, is enthusiastically breaking ground for its commercial vaccine production facility wit... […]
- Inspections find no concerns with vaccine production on September 7, 2018 at 11:59 pm
No quality and safety issues were found in vaccines that are currently under production in China, the State Drug Administration said after a thorough inspection. After Changchun Changsheng Bio-tech Co ... […]
- Inspections find no concerns with vaccine production on September 7, 2018 at 5:29 pm
A law enforcement officer inspects vaccines at the Center for Disease Control and Prevention in Rong'an county of Liuzhou city in the Guangxi Zhuang autonomous region. [Photo by Tan Kaixing/China Dail... […]
- China launches nationwide probe on vaccine production on July 26, 2018 at 8:48 am
China's drug watchdog will launch a nationwide inspection of the country's vaccine enterprises after authorities halted the production at a vaccine giant amid public outrage. According to a statement ... […]
- China's vaccine maker ordered to stop production, subject to investigation on July 22, 2018 at 2:46 pm
BEIJING, July 22 (Xinhua) -- China's drug regulator said on Sunday that it has ordered Changchun Changsheng Life Sciences Limited to stop production and launched an investigation into the company over ... […]
via Bing News